U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2006
178
Name Type Language
HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Common Name English
HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 6 CAPSID PROTEIN ANTIGEN, A
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN COMPONENT OF GARDASIL
Brand Name English
GARDASIL 9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Common Name English
GARDASIL-9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Common Name English
L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 6
Common Name English
GARDASIL COMPONENT HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN
Brand Name English
SILGARD COMPONENT HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN
Brand Name English
L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 6 VACCINE
Common Name English
RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 6 L1 COMPONENT OF SILGARD
Brand Name English
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Common Name English
GARDASIL COMPONENT HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Common Name English
Classification Tree Code System Code
WHO-ATC J07BM01
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
EMA ASSESSMENT REPORTS SILGARD (AUTHORIZED: CONDYLOMATA ACUMINATA)
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
EMA ASSESSMENT REPORTS GARDASIL (AUTHORIZED: CONDYLOMATA ACUMINATA)
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
NDF-RT N0000183891
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
WHO-ATC J07BM03
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
NCI_THESAURUS C75791
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
Code System Code Type Description
FDA UNII
61746O90DY
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY
DAILYMED
61746O90DY
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY
NCI_THESAURUS
C77718
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY
EVMPD
SUB22591
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY
NDF-RT
N0000170916
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY Vaccines, Inactivated [Chemical/Ingredient]
RXCUI
85982
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
ALTERNATIVE
NDF-RT
N0000183364
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY Actively Acquired Immunity [PE]
DRUG BANK
DB10299
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY
RXCUI
798268
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY
NDF-RT
N0000175336
Created by admin on Sat Dec 16 03:01:45 GMT 2023 , Edited by admin on Sat Dec 16 03:01:45 GMT 2023
PRIMARY Papillomavirus Vaccines [Chemical/Ingredient]
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966